Evidence map›Paper›PMID 40898133›Full record

ArticleBMC psychiatry2025

Predictors of clinical trial discontinuation in trichotillomania: a secondary analysis of previous clinical trials.

Trenton Lam, Jon E Grant

Abstract read
In one paragraph

Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Trenton LamDepartment of Psychiatry & Behavioral Neuroscience, University of Chicago, Pritzker School of Medicine, 5841 S. Maryland Avenue, Chicago, IL, MC-3077, 60637, USA.
Jon E GrantDepartment of Psychiatry & Behavioral Neuroscience, University of Chicago, Pritzker School of Medicine, 5841 S. Maryland Avenue, Chicago, IL, MC-3077, 60637, USA. jongrant@uchicago.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParticipant discontinuation is a significant challenge in pharmacological trials for trichotillomania (hair-pulling disorder). Attrition in clinical trials reduces statistical power, introduces error, and potentially wastes financial and medical resources. Identifying predictors of discontinuation may help researchers enhance participant retention and improve study outcomes.

methodsData from five completed pharmacological trials for trichotillomania were aggregated, and participants were classified as either Discontinued or Completed. Differences in demographic and clinical variables between these groups were analyzed using a generalized linear mixed model.

resultsOf the 222 participants, 177 (80%) were categorized as the Completed group. Discontinued patients (20%) were more likely to have achieved higher levels of formal education and were more likely to have a history of depression.

conclusionsThis study is among the first to examine variables associated with discontinuation rates in trichotillomania trials. The results underscore the importance of addressing educational background and patient history of depression when assessing dropout risk. These findings can guide future research to better support participants at risk of discontinuing treatment.

Indexed as

Clinical Trials as TopicPatient DropoutsTrichotillomaniaAdultEducational StatusFemaleHumansMaleMiddle AgedClinical trialDiscontinuationDropoutPharmacotherapyTrichotillomania

Identifiers

PMID40898133
PMCPMC12403459

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.